The functions and regulation of the PTEN tumour suppressor: new modes and prospects

YR Lee, M Chen, PP Pandolfi - Nature reviews Molecular cell biology, 2018 - nature.com
PTEN is a potent tumour suppressor, and its loss of function is frequently observed in both
heritable and sporadic cancers. PTEN has phosphatase-dependent and phosphatase …

Extracellular‐signal‐regulated kinase/mitogen‐activated protein kinase signaling as a target for cancer therapy: an updated review

M Najafi, A Ahmadi, K Mortezaee - Cell biology international, 2019 - Wiley Online Library
Mitogen‐activated protein kinase (MAPK) signaling pathway is activated in a wide spectrum
of human tumors, exhibiting cardinal oncogenic roles and sustained inhibition of this …

An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer

M Chen, J Zhang, K Sampieri, JG Clohessy… - Nature …, 2018 - nature.com
Lipids, either endogenously synthesized or exogenous, have been linked to human cancer.
Here we found that PML is frequently co-deleted with PTEN in metastatic human prostate …

USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway

H Sun, B Ou, S Zhao, X Liu, L Song, X Liu, R Wang… - …, 2019 - thelancet.com
Background USP11 is an ubiquitin-specific protease that plays an important role in tumor
progression via different mechanisms. However, the expression and prognostic significance …

H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen‐Activated …

Z Huang, L Chu, J Liang, X Tan, Y Wang, J Wen… - …, 2021 - Wiley Online Library
Background and Aims Bone is the second most frequent site of metastasis for HCC, which
leads to an extremely poor prognosis. HCC bone metastasis is typically osteolytic, involving …

Anti-cancer auto-antibodies: Roles, applications and open issues

H de Jonge, L Iamele, M Maggi, G Pessino, C Scotti - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the main causes of death worldwide and early detection
is crucial for effective treatment. Scientists have therefore focused on the identification of …

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation

R Chen, X Pang, L Li, Z Zeng, M Chen, S Zhang - Cell Death & Disease, 2022 - nature.com
The exact pathogenesis of inflammatory bowel disease (IBD), a chronic gastrointestinal
inflammatory disease comprising Crohn's disease and ulcerative colitis, remains unclear …

A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the …

B Huang, J Ren, Q Ma, F Yang, X Pan, Y Zhang, Y Liu… - Molecular Cancer, 2024 - Springer
Background Clear cell renal cell carcinoma (ccRCC) is the most prevalent kidney cancer
with high aggressive phenotype and poor prognosis. Accumulating evidence suggests that …

PPP1R14B is a prognostic and immunological biomarker in pan-cancer

M Deng, L Peng, J Li, X Liu, X Xia, G Li - Frontiers in genetics, 2021 - frontiersin.org
Recent studies have shown that PPP1R14B was highly expressed in tumor tissues and
patients with high expression of PPP1R14B had poor survival rates. However, the function …

ITCH as a potential therapeutic target in human cancers

Q Yin, CJ Wyatt, T Han, KSM Smalley, L Wan - Seminars in cancer biology, 2020 - Elsevier
Abstract The ITCH/AIP4 ubiquitin E3 ligase was discovered independently by two groups
searching for atrophin-1 interacting proteins and studying the genetics of mouse coat color …